Amphastar Pharmaceuticals (AMPH) Other Working Capital Changes (2013 - 2026)

Amphastar Pharmaceuticals' Other Working Capital Changes history runs 14 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 173.97% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $5.0 million, a 56.01% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 67.09% from the prior year.
• Other Working Capital Changes advanced to $2.3 million in Q1 2026 per AMPH's latest filing, from -$9.8 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $10.7 million in Q3 2024 and bottomed at -$9.8 million in Q4 2025.
• The 5-year median for Other Working Capital Changes is $635000.0 (2023), against an average of $1.2 million.
• Across the five-year window, Other Working Capital Changes surged 1589.76% in 2024 and plunged 4246.84% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $3.2 million in 2022, then fell by 11.36% to $2.8 million in 2023, then sank by 91.63% to $237000.0 in 2024, then plunged by 4246.84% to -$9.8 million in 2025, then jumped by 123.67% to $2.3 million in 2026.
• Per Business Quant, the three latest AMPH Other Working Capital Changes figures stand at $2.3 million (Q1 2026), -$9.8 million (Q4 2025), and $7.9 million (Q3 2025).